Russia Healthcare and Pharmaceutical Sector Report 2016/2017

  • ID: 4313102
  • Report
  • Region: Russia
  • 71 pages
  • EMIS, An ISI Emerging Markets Group Company
1 of 5
The Russian Market For Pharmaceuticals And Medical Equipment Has Remained Highly Dependent On Imported Products, Which, Together With The Weak Ruble, Has Substantially Reduced The Purchasing Power Of Russian Households.

FEATURED COMPANIES

  • OJCS Katren
  • PJSC OTPharm
  • PJSC Pharmstandard
  • Protek Group
  • Veropharm
  • MORE
This report provides a complete and detailed analysis of the healthcare and pharmaceutical sector for Russia. We present in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

Understand the key elements at play in the healthcare and pharmaceutical sector in Russia
Access forecasts for growth in the sector
View key data on healthcare spending and health insurance in Russia
Crystallise the forces both driving and restraining this sector in Russia
Build a complete perspective on sector trade, investment and employment
Understand the competitive landscape and who the major players are
View M&A activity and major deals
Gain an understanding of the regulatory environment for the sector in Russia
Build a clear picture of trends and issues for sub-sectors (medical institutions, pharmaceuticals manufacturing and distribution channels).
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • OJCS Katren
  • PJSC OTPharm
  • PJSC Pharmstandard
  • Protek Group
  • Veropharm
  • MORE
01 EXECUTIVE SUMMARY
Sector in Numbers 2015
Sector Overview
Sector Snapshot
Sector Outlook
Driving Forces
Restraining Forces
02 SECTOR IN FOCUS
Main Economic Indicators
Main Sector Indicators
Health Expenditure
Health Expenditure – Public
Health Expenditure – Private
Health Expenditure – Households
External Trade
Imports
Exports
Prices
Enterprises Statistics
Healthcare Resources
Financial Investment
Employment
03 COMPETITIVE LANDSCAPE
Highlights
Top Companies
Top M&A Deals
M&A Activity, 2015-2016
04 REGULATORY ENVIRONMENT
Key Bodies
Government Policy
05 COMPANIES IN FOCUS
Protek Group
PJSC Pharmstandard
OJCS Katren
PJSC OTPharm
Veropharm
06 PHARMACEUTICALS
Focus Point
Highlights
Production
Sales
External Sector
Imports
07 MEDICAL EQUIPMENT
Highlights
Production
Imports
Exports
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • OJCS Katren
  • PJSC OTPharm
  • PJSC Pharmstandard
  • Protek Group
  • Veropharm
  • MORE
The Russian healthcare and pharmaceutical sector is suffering under the impact of ongoing recession in the Russian economy and depressed domestic demand. The healthcare system is in dire need of financing as lower oil prices and a sharply devalued ruble have made the centralised, federal budget-funded healthcare system model inefficient. The Russian market for pharmaceuticals and medical equipment has remained highly dependent on imported products, which, together with the weak ruble, has substantially reduced the purchasing power of Russian households. Lack of adequate financing is causing massive protests by medical employees and patients, while out-of-pocket health expenditure has remained at constantly high levels, given the underdeveloped state health-insurance system.
Note: Product cover images may vary from those shown
5 of 5
Protek Group
PJSC Pharmstandard
OJCS Katren
PJSC OTPharm
Veropharm
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll